- Home
- NCA vs ZBIO Comparison
NCA vs ZBIO Comparison
Compare NCA & ZBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCA
- ZBIO
- Stock Information
- Founded
- NCA 1987
- ZBIO 2019
- Country
- NCA United States
- ZBIO United States
- Employees
- NCA N/A
- ZBIO N/A
- Industry
- NCA Investment Managers
- ZBIO
- Sector
- NCA Finance
- ZBIO
- Exchange
- NCA Nasdaq
- ZBIO NYSE
- Market Cap
- NCA N/A
- ZBIO 389.2M
- IPO Year
- NCA N/A
- ZBIO 2024
- Fundamental
- Price
- NCA $8.64
- ZBIO $9.29
- Analyst Decision
- NCA
- ZBIO Strong Buy
- Analyst Count
- NCA 0
- ZBIO 7
- Target Price
- NCA N/A
- ZBIO $32.29
- AVG Volume (30 Days)
- NCA 59.6K
- ZBIO 160.5K
- Earning Date
- NCA 01-01-0001
- ZBIO 05-20-2025
- Dividend Yield
- NCA 3.92%
- ZBIO N/A
- EPS Growth
- NCA N/A
- ZBIO N/A
- EPS
- NCA N/A
- ZBIO N/A
- Revenue
- NCA N/A
- ZBIO $5,000,000.00
- Revenue This Year
- NCA N/A
- ZBIO N/A
- Revenue Next Year
- NCA N/A
- ZBIO N/A
- P/E Ratio
- NCA N/A
- ZBIO N/A
- Revenue Growth
- NCA N/A
- ZBIO N/A
- 52 Week Low
- NCA $7.77
- ZBIO $5.83
- 52 Week High
- NCA $9.12
- ZBIO $26.25
- Technical
- Relative Strength Index (RSI)
- NCA 62.72
- ZBIO N/A
- Support Level
- NCA $8.42
- ZBIO N/A
- Resistance Level
- NCA $8.58
- ZBIO N/A
- Average True Range (ATR)
- NCA 0.09
- ZBIO 0.00
- MACD
- NCA 0.03
- ZBIO 0.00
- Stochastic Oscillator
- NCA 100.00
- ZBIO 0.00
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.